Coty launches Scientific Advisory Board to "shape the future of skincare"

Coty, one of the largest beauty conglomerates with a portfolio including Kylie Cosmetics, Burberry, Rimmel and more, has announced the launch of its first Scientific Advisory Board.

The Advisory Board brings together globally renowned scientific experts from diverse technical disciplines, selected for their unique expertise and contribution to cutting-edge research.

The board will convene twice a year to inform and inspire breakthrough innovations within Coty’s R&D specialists, which will push forward and shape “the future of skincare”.

The inaugural meeting of the Scientific Advisory Board took place at Coty’s Center of Excellence in Monaco, where one of the company’s flagship skincare brands was founded 70 years ago. The meeting brought together leading scientists to discuss the current themes in skin health and skin repair, which will influence Coty’s product innovation strategies.

Sue Nabi, CEO of Coty, said: “This year marks our 120th anniversary as pioneers in the beauty industry, and I’m honoured that such acclaimed scientific minds have agreed to come together to help define the future of Coty skincare as part of our Scientific Advisory Board. Each member has been carefully selected because they are at the forefront of their respective disciplines.

"Their ongoing insights will play a pivotal role as we continue to collaborate and drive skincare innovation forward for the benefit of all our consumers."

The board's members include:

• Dr. Miriam Merad, MD, PhD – Director of Precision Immunology Institute - New York
• Dr. Emma Guttman, MD, PhD – Professor of Dermatology & Immunology - New York
• Dr. Patrick Bui, MD – Head of Plastic Surgery Department American Hospital - Paris
• Pr. Selim Aractingi, MD, PhD – Team Leader, Cutaneous Biology Labs, Cochin Institute - Paris
• Pr. Wei Liu, MD, PhD – Dermatologist - Beijing
• Pr. Deng Xingwang – Professor of Life Science - Beijing
• Dr. Jaci Santana, MD – Dermatologist – Recife

This news follows last month's publishing of Coty's full-year financial report. The company confirmed "beauty maintains its privileged position" after revealing its financial results for the fiscal year 2024, were "ahead of or in-line with expectations".

During the fourth quarter, Coty's net revenues grew by 1% on a reported basis. The Q4 reported sales growth was supported by growth in both prestige and mass fragrances, prestige cosmetics and mass skin & body care. In FY24, total net revenues grew by 10% on a reported basis, ahead of the global beauty market which grew approximately by 9%.